[Elsevier] Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial |
|
This post will be closed automatically in 2026-07-18 07:35
Reward10points
|
post
reply
points
300
30
La place du psychologue dans la d谷cision m谷dicale partag谷e en soins palliatifs
10
Neuropathology of the temporal lobe
10
Mechanistic dissection of SMARCA2/4 molecular glues reveals programmable switching between DCAF16 and FBXO22
10
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial
10
Studies on heterogeneous cation-exchange membranes
